Waszczykowska, A.; PodgĂłrski, M.; Waszczykowski, M.; Gerlicz- Kowalczuk, Z.; Jurowski, P.
Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis—Case Series Report. Int. J. Mol. Sci. 2020, 21, 8703.
https://doi.org/10.3390/ijms21228703
AMA Style
Waszczykowska A, PodgĂłrski M, Waszczykowski M, Gerlicz- Kowalczuk Z, Jurowski P.
Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis—Case Series Report. International Journal of Molecular Sciences. 2020; 21(22):8703.
https://doi.org/10.3390/ijms21228703
Chicago/Turabian Style
Waszczykowska, Arleta, Michał Podgórski, Michał Waszczykowski, Zofia Gerlicz- Kowalczuk, and Piotr Jurowski.
2020. "Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis—Case Series Report" International Journal of Molecular Sciences 21, no. 22: 8703.
https://doi.org/10.3390/ijms21228703
APA Style
Waszczykowska, A., PodgĂłrski, M., Waszczykowski, M., Gerlicz- Kowalczuk, Z., & Jurowski, P.
(2020). Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis—Case Series Report. International Journal of Molecular Sciences, 21(22), 8703.
https://doi.org/10.3390/ijms21228703